arrow_back Back to App

Veterans' Medication Rights: Written Consent Required for Key Drugs.

This bill mandates the Veterans Health Administration (VHA) to obtain written informed consent from veterans before prescribing a wider range of powerful medications. This expands existing rules for opioids to include psychiatric drugs and stimulants. The goal is to enhance patient safety and ensure veterans are fully informed about the risks and benefits before starting treatment.
Key points
The requirement for written consent now applies to a broader range of psychiatric and pain medications for veterans using the VHA.
New rules cover antidepressants, antipsychotics, stimulants, anxiolytics (anti-anxiety drugs), and narcotics, increasing patient autonomy.
Veterans must knowingly consent to treatment with these medications, ensuring full awareness of potential side effects and risks.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4837
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
Process start date: 2025-08-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Written Informed Consent Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4837.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-08-01.

What are the main provisions?

Key points include:

  • The requirement for written consent now applies to a broader range of psychiatric and pain medications for veterans using the VHA.
  • New rules cover antidepressants, antipsychotics, stimulants, anxiolytics (anti-anxiety drugs), and narcotics, increasing patient autonomy.
  • Veterans must knowingly consent to treatment with these medications, ensuring full awareness of potential side effects and risks.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bilirakis, Gus M. [R-FL-12].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

CATEGORIES

Health Benefits